A carregar...

Allogeneic hematopoietic cell transplantation for MDS: For whom, when and how?

Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for patients with myelodysplastic syndrome (MDS). However, treatment-related mortality and relapse have remained major barriers to uniform success. Therefore, important questions remain to be answered, s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gyurkocza, Boglarka, Deeg, H. Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509173/
https://ncbi.nlm.nih.gov/pubmed/22981712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2012.08.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!